Blocking IL-2 and IL-12 significantly reduces GM-CSF expression by Tc, NK, and B cells in MS patients but not in these cell types for HCs, implicating IL-2 and IL-12 as important stimulatory pathways for GM-CSF in MS. The gene discussed is IL2; the disease is myeloid sarcoma.